Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Therapy-Related AML (t-AML), a Heterogeneous Disease: Multicenter Analysis on Biological and Clinical Differences between Cases Following Breast Cancer and Lymphoma Treatment

Giambattista Bertani, MD, Fabio Guolo, MD, Valentina Mancini, MD, Rosa Greco, MD, Paola Minetto, MD PhD, Monica Passannante, MD, Roberto Massimo Lemoli, MD, Roberto Cairoli

Blood (2020) 136 (Supplement 1): 31.

https://doi.org/10.1182/blood-2020-138866

Published: 2020

Journal Articles

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Marta Riva, Lorenzo Rizzo, MD, Valentina Mancini, MD, Rosa Greco, MD, Giambattista Bertani, MD, Elisa Zucchetti, MD, Elisa Diral, MD, Michele Nichelatti, PhD, Silvio Marco Veronese, Giovanni Grillo, MD, Roberto Cairoli

Blood (2020) 136 (Supplement 1): 20–21.

https://doi.org/10.1182/blood-2020-141987

Published: 2020

Journal Articles

Treatment of Elderly Patients with Acute Promyelocytic Leukemia: A Real Life Experience of the "Rete Ematologica Lombarda"

Valentina Mancini, MD, Erika Borlenghi, MD, Livia Leuzzi, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Patrizia Zappasodi, MD, Monica Fumagalli, MD, Elisabetta Todisco, MD PhD, Chiara Cattaneo, MD, Federico Lussana, MD, Giambattista Bertani, MD, Erika Ravelli, MD, Nicola Fracchiolla, Mauro Turrini, Giuseppe Rossi, Silvia Cantoni, Roberto Cairoli, MD

Blood (2019) 134 (Supplement_1): 3862.

https://doi.org/10.1182/blood-2019-130089

Published: 2019

Journal Articles

Administration of Plerixafor in Poor Mobilizers Allows Mobilization of Haematopoietic Progenitors: Clonogenic Potential and Engraftment Analysis

Laura Pezzetti, MSc, Giambattista Bertani, MD, Liliana Intropido, MSc, Tiziana Lamacchia, MSc, Mariateresa Pugliano, MD, Elisabetta Bice Volpato, MD, Elisa Zucchetti, MD, Giovanni Grillo, MD, Roberto Cairoli, MD

Blood (2019) 134 (Supplement_1): 5633.

https://doi.org/10.1182/blood-2019-125055

Published: 2019

Journal Articles

Refining Hellström-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?

Marta Riva, MD, Gianluigi Reda, MD, Emanuele Ravano, MD, Ramona Cassin, MD, Mariarita Sciumè, MD, Pierangelo Spedini, MD, Giambattista Bertani, MD, Michele Nichelatti, PhD, Agostino Cortelezzi, Prof, Roberto Cairoli, MD, Alfredo Molteni, MD

Blood (2017) 130 (Supplement 1): 2981.

https://doi.org/10.1182/blood.V130.Suppl_1.2981.2981

Published: 2017

Journal Articles

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Giovanni Grillo, MD, Ivana Lotesoriere, MD, Elisa Zucchetti, MD, Valentina Mancini, MD, Barbara Forno, MD, Giambattista Bertani, MD, Elena Inzoli, MD, Silvia Soriani, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5550.

https://doi.org/10.1182/blood.V130.Suppl_1.5550.5550

Published: 2017

Journal Articles

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Giovanni Grillo, MD, Elisa Zucchetti, MD, Elena Inzoli, MD, Valentina Mancini, MD, Barbara Forno, MD, Ivana Lotesoriere, MD, Giambattista Bertani, MD, Roberto Cairoli, MD

Blood (2017) 130 (Supplement 1): 5553.

https://doi.org/10.1182/blood.V130.Suppl_1.5553.5553

Published: 2017

NARROW

Therapy-Related AML (t-AML), a Heterogeneous Disease: Multicenter Analysis on Biological and Clinical Differences between Cases Following Breast Cancer and Lymphoma Treatment

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Treatment of Elderly Patients with Acute Promyelocytic Leukemia: A Real Life Experience of the "Rete Ematologica Lombarda"

Administration of Plerixafor in Poor Mobilizers Allows Mobilization of Haematopoietic Progenitors: Clonogenic Potential and Engraftment Analysis

Refining Hellström-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Therapy-Related AML (t-AML), a Heterogeneous Disease: Multicenter Analysis on Biological and Clinical Differences between Cases Following Breast Cancer and Lymphoma Treatment

Enasidenib, an Oral Therapy in Mutant IDH2 Relapsed/Refractory Acute Myeloid Leukemia: A Real-Life Single Center Experience

Treatment of Elderly Patients with Acute Promyelocytic Leukemia: A Real Life Experience of the "Rete Ematologica Lombarda"

Administration of Plerixafor in Poor Mobilizers Allows Mobilization of Haematopoietic Progenitors: Clonogenic Potential and Engraftment Analysis

Refining Hellström-Lindberg Score: Which Patients Could Benefit from Standard Dose EPO?

Retrospective Monocentric Study on Acute Myeloid Leukemias with Complex Karyotype: Clinical Outcomes and Cytogenetic Features

Impact of FLT3-ITD Mutations in Patients with Normal Karyotype Acute Myeloid Leukemia Undergoing Allogeneic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only